KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Dynavax Technologies (DVAX) over the last 13 years, with Q2 2024 value amounting to $14.9 million.

  • Dynavax Technologies' Non-cash Items rose 12298.73% to $14.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $14.9 million, marking a year-over-year increase of 12298.73%. This contributed to the annual value of $7.0 million for FY2023, which is 5694.56% down from last year.
  • Dynavax Technologies' Non-cash Items amounted to $14.9 million in Q2 2024, which was up 12298.73% from $7.7 million recorded in Q1 2024.
  • In the past 5 years, Dynavax Technologies' Non-cash Items ranged from a high of $46.6 million in Q3 2023 and a low of $4.8 million during Q1 2020
  • Over the past 5 years, Dynavax Technologies' median Non-cash Items value was $6.9 million (recorded in 2023), while the average stood at $13.3 million.
  • Per our database at Business Quant, Dynavax Technologies' Non-cash Items surged by 9773333.33% in 2020 and then crashed by 6901.33% in 2023.
  • Quarter analysis of 5 years shows Dynavax Technologies' Non-cash Items stood at $5.6 million in 2020, then skyrocketed by 670.24% to $42.8 million in 2021, then tumbled by 61.9% to $16.3 million in 2022, then crashed by 56.95% to $7.0 million in 2023, then surged by 112.85% to $14.9 million in 2024.
  • Its Non-cash Items stands at $14.9 million for Q2 2024, versus $7.7 million for Q1 2024 and $7.0 million for Q4 2023.